The authors describe the results of a clinical-observational study on Takotsubo Cardiomyopathy (TC)
Major issues to be revised -Aims of the study are not well defined, because of unspecified outcomes to be considered. -There is a serious inconsistency between the type of the study declared by authors ("observational" on title, "prospective" in discussion, line 14-15) and stated limitations ("retrospective", line 5 page 9). The authors should better clarify. -The length of follow-up is confusing. The authors often present their results as from a long-term follow-up (6 years in discussion, line 14), but the mean length was 2.2 years (line 53-57 page 7), with a maximum of 6.8 years (maybe, by a small number of patients). Their declaration, however, seems to be inconsistent with SD (±2.0). Unfortunately, this cannot be identified as a long-term observational study. -The manuscript is lacking tables with clinical and demographic characteristics of the study population, as well as outcomes over the follow-up.
-Authors report only the diagnostic criteria by the Mayo-clinic (table 1) , which are -at least in part -obsolete. On the other hand, "Guidelines for diagnosis of TC" are also available from the Study Group on TC (Kaway et al, Circ J 2007) . Why did they just cite the American ones? In my opinion, at the time being, it is not necessary to report the diagnostic criteria for TC, but to follow them. - Table 2 
Minor issues to be revised
-The correct definition of disease is: Takotsubo-like Cardiomyopathy or Stress Cardiomyopathy. -There are lots of mistakes in punctuation (do not use commas for decimals, use commas for thousands only, full stop for percents). Numerical findings should be reported as number (and percent) [n(%)], uniformly through text. -Preliminary description (background section) of the Syndrome is not necessary, because it is well known. -Some data should be better explained: 1) Door to balloon was 90 minutes in 32 pts and 36 hours in 43
pts. Why such a big difference? Given that the majority of patients has been recognized as ACS, were different protocols applied for urgent coronary angiography within the study population? 2) Apical thrombus was recognized in one patient only (1.3%).
But, have the patients been monitored by echo all through the hospital stay? In this account, the authors report single case references on thrombosis. It should be better to report at least one of the two systematic reviews on this subject (de Gregorio, Int J Cardiol 2008 and 2010 ). 3) Results should be reported in order as follows: clinical findings, ECG, ECHO, Angiography, CMR, follow-up, outcomes. 4) Line 13, page 7: "mid and basal segments of the heart" likely means "mid and basal segments of the LV"? 5) Delayed-enhancement CMR is not of clinical interest on this context: data should be reported in the diagnostic flow-chart, to confirm the lack of myocardial necrosis, e.g. in patients with coronary artery atherosclerosis.
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GENERAL COMMENTS
The paper does not provide new insights on clinical features and/or outcome of Tako-tsubo syndrome.
REVIEWER
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REVIEW RETURNED
29-Jun-2012
GENERAL COMMENTS
The long-term follow-up of takotsubo cardiomyopathy described in this study over a period of 6 years on 75 patients increase knowledge about this syndrome.
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THE STUDY
The paper addresses the natural history of Takotsubo cardiomyopathy and there is not very much published on this. The authors have used the old Mayo criteria and I think it would be helpful to point out these have now been amended and do not require the absence of neurological trauma or intracranial haemorrhage. The other thing that needs to be made clearer is how myocarditis was ruled out as this is a major differential diagnosis, but the authors do not clearly state how this was excluded -simply that it was. Overall the standard of English is fair, but the manuscript would benefit from a good proof-reading for grammar and English RESULTS & CONCLUSIONS The authors cite a good range of relevant previous work, but they say surprisingly little about the Sharkey paper published in JACC (reference 36). This is one of the largest series I know on the natural history of this condition and I think it would improve the paper to discuss their findings in the light of those reported by Sharkey, which are generally similar except that the mortality in follow up was rather higher.
VERSION 1 -AUTHOR RESPONSE
Reviewer: Cesare de Gregorio, MD, Researcher and Aggregate Professor, Cardiovascular Medicine. Clinical and experimental Dpt of Medicine and Pharmacology. University of Messina, Messina, Italy.
We are grateful for your suggestions. According to your suggestion we have modified the text as you can evaluate. In particular:
Major issues
The aim of the current study was to assess the recurrence rate of takotsubo-like cardiomyopathy after initial presentation and define more completely the broad clinical features and survival of this recently recognized condition. None of 75 patients died in acute phase. At a mean follow-up time of 2.2 ± 2 years (range 0.1 to 6.8 years) 2 octogenarian patients (2.6%) died because of sudden cardiac death and pulmonary embolism respectively. The takotsubo-like cardiomyopathy recurred in 1 patient.
We have readed the type of the study About the length of follow-up, we describe our clinical experience over a period of 6-years (between February 2004 and November 2010) on 75 patients but follow-up information was available for only 56 patients with a mean follow-up time of 2.2 ± 2 years (range 0.1to 6.8 years). according to your suggestion we have removed the word long-term follow-up in the text as you can evaluate.
We have added the table with clinical and demographic characteristics of the study population
We have added in the criteria the absence of neurological trauma or intracranial hemorrhage.
We have readed final message About any aspects of the syndrome: in our series only in 1 patient TC recurred and this patient at the moment of the second episode used only aspirin and didn't use beta-blockers and angiotensinconverting enzyme nor inhibitors/angiotensin receptor blockers. Curiously the patient didn't have an identifiable precipitating event at first episode and at recurrence. During follow-up, in 4 patients occurred emotional stressors such as an unexpected death in the family but they didn't have a recurrence of TC. It is unclear why recurrences of TC do not occur when similar stressful circumstances may occur after the initial episode. In these cases the patients used beta-blockers, angiotensin-converting enzyme inhibitors and aspirin Elesber et al, showed that TC recurred in 10 patients over a mean follow-up of 4.4 ± 4.6 years and there was no difference between the patients who did and did not have recurrence in the use of aspirin, angiotensin-converting enzyme, inhibitors/angiotensin receptor blockers, beta-blockers, and statins. Moreover Sharkey et al. showed that three of 7 patients were taking beta-blocking agents at the time of their first recurrent SC event
Minor issues
We have modified the definition
